NasdaqCM - Nasdaq Real Time Price USD

China SXT Pharmaceuticals, Inc. (SXTC)

Compare
0.5643 +0.0096 (+1.73%)
At close: September 10 at 4:00 PM EDT
0.7900 +0.23 (+40.00%)
Pre-Market: 6:35 AM EDT
Loading Chart for SXTC
DELL
  • Previous Close 0.5547
  • Open 0.5860
  • Bid 0.3955 x 200
  • Ask 0.6919 x 200
  • Day's Range 0.5420 - 0.5888
  • 52 Week Range 0.5300 - 6.3900
  • Volume 41,979
  • Avg. Volume 430,069
  • Market Cap (intraday) 1.962M
  • Beta (5Y Monthly) 1.13
  • PE Ratio (TTM) --
  • EPS (TTM) -3.5700
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

www.sxtchina.com

75

Full Time Employees

March 31

Fiscal Year Ends

Recent News: SXTC

View More

Performance Overview: SXTC

Trailing total returns as of 9/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SXTC
85.79%
S&P 500
15.21%

1-Year Return

SXTC
81.03%
S&P 500
23.29%

3-Year Return

SXTC
97.89%
S&P 500
22.31%

5-Year Return

SXTC
99.75%
S&P 500
84.51%

Compare To: SXTC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SXTC

View More

Valuation Measures

Annual
As of 9/10/2024
  • Market Cap

    1.96M

  • Enterprise Value

    -7.46M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.25

  • Price/Book (mrq)

    0.14

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -160.67%

  • Return on Assets (ttm)

    -4.97%

  • Return on Equity (ttm)

    -21.65%

  • Revenue (ttm)

    1.93M

  • Net Income Avi to Common (ttm)

    -3.1M

  • Diluted EPS (ttm)

    -3.5700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.07M

  • Total Debt/Equity (mrq)

    26.52%

  • Levered Free Cash Flow (ttm)

    -1.22M

Company Insights: SXTC

People Also Watch